UK
-
UKHSA targets breeding Aedes aegypti mosquitoes in East London
Although Aedes aegypti mosquitoes have been detected in the UK several times in recent years, the latest findings provide the first evidence that the species is actively breeding in Britain.
-
Polaroid Therapeutics secures MHRA approval for POLTX_Fibers™ wound dressing
Polaroid Therapeutics designed POLTX_Fibers™ to help reduce infection risk while supporting wound healing at the point of care.
-
Eli Lilly wins UK MHRA approval for Foundayo weight-loss pill
The approval from the Medicines and Healthcare products Regulatory Agency (MHRA) marks another milestone in the rapidly growing market for oral weight-loss medicines.
-
Newcastle Hospitals performs UK’s first adolescent spinal cord stimulation implantation
Dr Sachin Rastogi, consultant anaesthetist, and Akbar Hussain, consultant neurosurgeon and functional neurosurgeon, performed the procedure at the Royal Victoria Infirmary, part of the Newcastle Hospitals group.
-
Oxford begins human trials for the experimental Bundibugyo Ebola vaccine
The experimental vaccine was developed by scientists at the University of Oxford using the same vaccine technology employed in the Oxford-AstraZeneca COVID-19 vaccine.
-
Kyowa Kirin extends Crysvita EU orphan market exclusivity to February 2030
The approval follows a positive recommendation issued in April 2026 by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
-
GSK secures first lung cancer approval days after US$10.6B Nuvalent acquisition
The US Food and Drug Administration (FDA) approved Jideytro for adults with locally advanced or metastatic ROS1-positive NSCLC who have previously received treatment with a ROS1 kinase inhibitor.
-
Beckman Coulter secures EU CE mark for Access p-Tau217 Alzheimer’s blood test
The approval allows laboratories across Europe and other CE-recognising markets to use the assay to support the clinical evaluation of amyloid pathology in people showing signs of cognitive decline.
-
Codis buys Catalent Nottingham Facility to expand UK CDMO capacity
The Nottingham site also supports Codis’ commercial spray-drying operations in Haverhill, U.K., where the company is increasing capacity by installing a new GEA Pharma-SD PSD-4 commercial spray dryer, with validation planned for 2027.
-
Clarivate to sell Life Sciences & Healthcare business to Altaris in US$600M deal
Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.